Dr. Igor Zilberman, MD

Dr. Zilberman practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Zilberman's NPI, 1245498195, was assigned on May 28, 2008. Dr. Zilberman graduated from SUNY Downstate Health Sciences University in 2003. Dr. Zilberman holds New York license 238821.

Dr. Zilberman's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Dr. Zilberman's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Zilberman is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Zilberman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zilberman practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Zilberman's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Zilberman is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Zilberman's licenses on file in 2 states: New York and New Jersey.

CMS data shows 531 Medicare services from Dr. Zilberman across 6 procedure codes in 2024, for 330 Medicare patients. Medicare paid $48,588 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 330 Medicare patients who saw Dr. Zilberman in 2024. The largest group is 75 to 84, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zilberman's median patient age at 65, with 53% women.

In 2024, Dr. Zilberman wrote 14 Medicare Part D claims. 79% of them were for generic drugs. They cover 2 drugs, with $386 in total drug cost. In 2018, CMS named 182 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zilberman for performance year 2024, reported through an alternative payment model (APM). Dr. Zilberman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zilberman as offering telehealth.

CMS Open Payments shows 22 general payments to Dr. Zilberman from 12 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Amarin Pharma Inc. paid the most, $76.

Dr. Zilberman graduated from SUNY Downstate Health Sciences University in 2003.

Dr. Zilberman is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.